1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. ARCELLX INC
Arcellx Inc XNAS: ACLX

Arcellx Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology...

Read More
72.18 0.64 (0.89%)
32.77% Fall from 52W High
75,393
XNAS Volume

XNAS 31 Jul, 2025 11:39 AM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Arcellx Inc is on 08 Aug 2025 for the purpose of Arcellx Inc Second Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
5.7 / 100
Momentum Score
Technically Neutral
56.0 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
114
1Yr Price target upside is 58%
15 analysts

9

S

11

W

0

O

3

T

SWOT Analysis

Arcellx Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..